A PHASE II TRIAL EVALUATING THE SAFETY AND EFFICACY OF MR-LINAC- GUIDED RADIOTHERAPY AS SALVAGE TREATMENT AFTER EXTERNAL BEAM RADIOTHERAPY RECURRENCE (TUMORNATOR II)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Prostate
  • Age: Between 18 Year(s) - 99 Year(s)
  • Gender: Male
  • Other Inclusion Criteria:
    In order to participate in this study the following conditions must be met:
    1. 18 years of age or older male participants.
    2. Biopsy proven intraprostatic prostate cancer after prior definitive external beam radiotherapy (moderate hypofractionation or SBRT acceptable). NOTE: Seminal vesicle involvement allowed
    3. Pathology confirming recurrent disease must have evidence of viable cancer as indicated with pathology interpretation where a Gleason score can be assigned

You may not be eligible for this study if the following are true:

  • You will not be able to participate in this study if you have:
    1. History of prostate brachytherapy (low dose rate or high dose rate)
    2. Actively undergoing androgen deprivation therapy and/or anti-androgens at time of enrollment
    3. CT or MRI or PET scan evidence of extraprostatic disease



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.